drugset / Trial / NCT00031759

Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia

NCT00031759 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development of cancer. Applying topical imiquimod before abnormal cervical cells are removed may be effective in preventing cervical cancer. PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod before abnormal cervical cells are removed in preventing cervical cancer in patients who have recurrent or persistent cervical neoplasia.

Timeline

Start
1999-06
Primary completion
2004-07
Completion
2010-02

Outcome

Missed primary endpoint

paper There were no differences in dysplasia recurrence between the 2 groups. PMID 21907959 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified — Topical